| Patents for C07K 19 - Hybrid peptides (29,428) | 
|---|
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides | 
| 12/29/1997 | EP0631586B1 Amino procollagen 1(i) peptides | 
| 12/24/1997 | WO1997048724A2 Human metabotropic glutamate receptor | 
| 12/24/1997 | WO1997048275A1 Endoderm, cardiac and neural inducing factors | 
| 12/24/1997 | CN1168676A Materials for the production of nanometer structures and use thereof | 
| 12/24/1997 | CN1168674A Synthetic peptides and vaccines comprising same | 
| 12/24/1997 | CA2258789A1 Endoderm, cardiac and neural inducing factors | 
| 12/24/1997 | CA2246751A1 Human metabotropic glutamate receptor | 
| 12/23/1997 | US5700680 Fusion proteins | 
| 12/23/1997 | US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use | 
| 12/18/1997 | WO1997047732A2 Hexameric fusion proteins and uses therefor | 
| 12/18/1997 | CA2257861A1 Hexameric fusion proteins and uses therefor | 
| 12/17/1997 | EP0812358A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation | 
| 12/17/1997 | EP0812357A1 A method for making heteromultimeric polypeptides | 
| 12/17/1997 | EP0812352A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras | 
| 12/17/1997 | EP0812204A1 Codominance-mediated toxins | 
| 12/17/1997 | EP0612251B1 Stabilised antibodies | 
| 12/17/1997 | EP0494293B1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection | 
| 12/17/1997 | CN1167920A Safety human immunodeficiency virus antibody positive serum substitute | 
| 12/16/1997 | US5698424 Capsid forming and cystein modified chimaeric MS2-coat protein | 
| 12/16/1997 | US5698407 Method for the immunological determination of the carboxyterminal propeptide of type I procollagen | 
| 12/16/1997 | CA1339582C Monoclonal antibodies and methods for diagnosis of phytophthora infection | 
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy | 
| 12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer | 
| 12/11/1997 | CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer | 
| 12/10/1997 | EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease | 
| 12/10/1997 | EP0811069A1 Chimeric adenoviral fiber protein and methods of using same | 
| 12/10/1997 | EP0811065A1 Antagonists of interleukin-15 | 
| 12/10/1997 | EP0811061A1 Multiple-tumor aberrant growth genes | 
| 12/10/1997 | EP0811016A1 Synthetic peptide based immunogens for the treatment of allergy | 
| 12/10/1997 | CN1167505A Tie-2 ligands, methods of making and uses thereof | 
| 12/10/1997 | CN1167504A Tetracycline-regulated transcriptional modulators | 
| 12/10/1997 | CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer | 
| 12/10/1997 | CN1167155A Method for cleaving chimeric protein using processing enzyme | 
| 12/09/1997 | US5696237 Recombinant antibody-toxin fusion protein | 
| 12/09/1997 | US5696088 Chimeric proteins | 
| 12/09/1997 | US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms | 
| 12/09/1997 | US5695991 A complex between a virus the cell binding receptor of which has been inactivated and an antibody able to interact with specific antigen; antigen has ability to mediate entrance into mammalian cells | 
| 12/09/1997 | US5695953 DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production | 
| 12/09/1997 | US5695950 Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase | 
| 12/09/1997 | US5695758 Hybridoma cells | 
| 12/09/1997 | CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides | 
| 12/04/1997 | WO1997045746A2 Prion protein binding proteins and uses thereof | 
| 12/04/1997 | WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS | 
| 12/04/1997 | WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis | 
| 12/04/1997 | WO1997038293A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto | 
| 12/04/1997 | CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis | 
| 12/04/1997 | CA2256312A1 Prion protein binding proteins and uses thereof | 
| 12/03/1997 | EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same | 
| 12/03/1997 | EP0600866B1 Compositions and methods for identifying biologically active molecules | 
| 12/02/1997 | US5693762 Humanized immunoglobulins | 
| 12/02/1997 | US5693761 Genetic engineering; complementarity zones | 
| 12/02/1997 | US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I | 
| 12/02/1997 | US5693752 Hexapeptides of specified amino acid sequences | 
| 12/02/1997 | US5693477 Receptor membranes | 
| 11/29/1997 | CA2187728A1 Iron-regulated metal transporters and uses therefor | 
| 11/27/1997 | WO1997044481A1 Compositions and methods for screening antimicrobials | 
| 11/27/1997 | WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF | 
| 11/27/1997 | WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production | 
| 11/27/1997 | WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH | 
| 11/27/1997 | CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production | 
| 11/27/1997 | CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth | 
| 11/27/1997 | CA2255906A1 Human interleukin-1j and antagonists thereof | 
| 11/26/1997 | EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS | 
| 11/26/1997 | EP0808367A1 Mucosal vascular addressins and uses thereof | 
| 11/26/1997 | EP0542863B1 Expression of recombinant polypeptides with improved purification | 
| 11/25/1997 | US5691449 Respiratory syncytial virus vaccines | 
| 11/25/1997 | US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes | 
| 11/25/1997 | US5690928 Administering transforming growth factor | 
| 11/25/1997 | CA2099865C Hepatic growth factor receptor is the met proto-oncogene | 
| 11/20/1997 | WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿ | 
| 11/20/1997 | WO1997043310A1 Synthetic inhibitors of hepatitis c virus ns3 protease | 
| 11/20/1997 | WO1997035538A3 Tumor necrosis factor alpha convertase | 
| 11/20/1997 | CA2254122A1 Synthetic inhibitors of hepatitis c virus ns3 protease | 
| 11/19/1997 | EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) | 
| 11/19/1997 | EP0807181A1 NOVEL c-MPL LIGANDS | 
| 11/19/1997 | EP0807176A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma | 
| 11/19/1997 | EP0807173A1 Methods for producing immunoglobulins containing protection proteins in plants and their use | 
| 11/19/1997 | EP0663925A4 Affinity purification methods involving amino acid mimetics as elution reagents. | 
| 11/19/1997 | EP0541645B1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies | 
| 11/19/1997 | EP0341252B1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis | 
| 11/18/1997 | US5688767 Treatment of endotoxin-associated disorders with cationic peptides | 
| 11/18/1997 | US5688688 Vector for expression of a polypeptide in a mammalian cell | 
| 11/13/1997 | WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system | 
| 11/13/1997 | WO1997042325A1 B. burgdorferi polypeptides expressed in vivo | 
| 11/13/1997 | WO1997042224A1 Neurotactin and uses therefor | 
| 11/13/1997 | WO1997041824A2 Antiangiogenic peptides derived from plasminogen | 
| 11/13/1997 | CA2253864A1 Neurotactin and uses therefor | 
| 11/13/1997 | CA2253834A1 B. burgdorferi polypeptides expressed in vivo | 
| 11/13/1997 | CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system | 
| 11/12/1997 | EP0805819A1 Chimeric dna-binding proteins | 
| 11/12/1997 | EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof | 
| 11/12/1997 | EP0805686A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases | 
| 11/12/1997 | CN1164872A Novel compounds | 
| 11/11/1997 | US5686600 Antibodies which bind to insect gut proteins and their use | 
| 11/11/1997 | US5686583 Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy | 
| 11/11/1997 | US5686574 Constitutive activator of retinoid acid response (car) receptor fusion protien | 
| 11/11/1997 | US5686278 Methods for enhanced retrovirus-mediated gene transfer | 
| 11/11/1997 | US5686267 Nucleic acid molecule encoding antigen associated with lyme disease | 
| 11/11/1997 | US5686079 Oral immunization by transgenic plants |